Vericel Corp

Common Name
Vericel
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
357
Ticker
VCEL
Exchange
NASDAQ/NMS
Website
vcel.com
Description
Vericel Corporation is a biopharmaceutical company focused on the development and commercialization of innovative cellular therapies for patients with severe diseases and conditions. The company's pri...

Disclosures of Vericel

Explore Vericel's complete collection of publicly available corporate disclosures, including annual reports, sustainability reports, financial statements, ESG data spreadsheets, and related web publications. Each document is sourced directly from Vericel's official channels and fully traceable to its official company sources.

The table below lists all of Vericel's' corporate disclosure by name and reporting period, ensuring full transparency and easy access. Coming soon, Tracenable users will be able to export disclosures as PDFs, view them in Markdown, or open them directly in ChatGPT or Claude for instant analysis and summarization.

NameReporting Period
10-K2024
10-K2023
10-K2022
ESG Report2021
10-K2021
10-K2020
10-K2019
10-K2018
10-K2017
10-K2016
10-K2015
Real-Time Disclosures Datafeed

Get Notified Within Seconds of New Corporate Disclosures

Tracenable is building a high-speed disclosure monitoring system that delivers instant alerts when companies publish new reports or data. Could a real-time datafeed (via SFTP, RSS or API) enhance your investment or analytical workflows?